TODAY'S HEADLINES
The results of two large phase 3 clinical trials suggest that the drug secukinumab (Novartis) is a remarkably effective treatment for moderate-to-severe plaque psoriasis. » More
|
ADVERTISEMENT
Insights into managing atopic dermatitis and acne
Atopic dermatitis and acne have significant physical, psychosocial and financial impacts on patients. Keep current on the epidemiology and pathogenesis of both conditions and how these may impact patient care.
Read More.
|
Content related to dermatology and dermatologic conditions is widely available on YouTube, but identifying sources for some of the content remains a challenge, according to results of a recent study. » More
|
Topical ivermectin cream 1 percent has shown safety and statistically superior efficacy versus vehicle as early as week two of treatment in phase 3 trials. » More
|
ADVERTISEMENT
Best practices in the evaluation and management of actinic keratoses
Articles, video, tools and CME on current strategies for managing actinic keratoses lesions using a variety of therapeutic approaches based on efficacy, safety and tolerability.
Read More.
|
The Food and Drug Administration has approved tavaborole (Kerydin, Anacor) topical solution 5 percent, the first oxaborole antifungal approved for topical treatment of onychomycosis of the toenails. » More
|
|
|